Skip to main content

Creutzfeldt-Jakob Disease

Image
By

Overview

Creutzfeldt-Jakob Disease is a rapidly progressive degenerative disease of the nervous system that can be transmitted by blood or tissues between human beings.

Epidemiology

It is estimated that 50-100 cases occur each year in the UK, with an equal sex ratio and onset typically occurring between the ages of 40 and 60.

Aetiology

The disease is caused by the accumulation of an abnormal prion protein in the brain, which is encoded on chromosome 20. Those with the E4 allele of apolipoprotein are at a higher risk of developing the disease, and the familial form, known as Gerstmann-Straussler-Scheinker, accounts for 10% of patients and principally affects the cerebellum. It is also autosomal dominant.

Clinical Features

Clinical features of the disease can include personality changes, seizures, intellectual deterioration, and neurological deficits such as cerebellar ataxia, spasticity, extrapyramidal signs, and myoclonus sensitivity to noise or touch. In new-variant CJD (nvCJD), initial psychiatric symptoms are followed by a cerebellar syndrome leading to memory failure and akinetic mutism. There are four forms of the disease: subacute spongiform encephalopathy (SSE 1), which is rapidly fatal, SSE 2 (Heidenhaim’s – blindness and dementia), thalamic form, and ataxic form.

Investigations

Diagnosis can be confirmed by abnormal EEG results, which are present in 90% of patients, low voltage with bi/triphasic discharges, and repetitive complexes that coincide with the myoclonus. Atrophy may be apparent in the later stages with CT or MRI, and the CSF protein is sometimes moderately elevated.

Prognosis

The prognosis for Creutzfeldt-Jakob Disease is poor, with the disease progressing rapidly over the course of 1-2 years.

Labels:

Comments

Post a Comment

Your Thoughts?

Popular posts from this blog

ADVOKATE: A Mnemonic Tool for the Assessment of Eyewitness Evidence

By
ADVOKATE: A Mnemonic Tool for Assessment of Eyewitness Evidence A tool for assessing eyewitness  ADVOKATE is a tool designed to assess eyewitness evidence and how much it is reliable. It requires the user to respond to several statements/questions. Forensic psychologists, police or investigative officer can do it. The mnemonic ADVOKATE stands for: A = amount of time under observation (event and act) D = distance from suspect V = visibility (night-day, lighting) O = obstruction to the view of the witness K = known or seen before when and where (suspect) A = any special reason for remembering the subject T = time-lapse (how long has it been since witness saw suspect) E = error or material discrepancy between the description given first or any subsequent accounts by a witness.  Working with suspects (college.police.uk)
Post a Comment
Read more

ICD-11 Criteria for Anorexia Nervosa (6B80)

By
ICD-11 Criteria for Anorexia Nervosa (6B80) Anorexia Nervosa is characterised by significantly low body weight for the individual’s height, age and developmental stage that is not due to another health condition or to the unavailability of food. A commonly used threshold is body mass index (BMI) less than 18.5 kg/m2 in adults and BMI-for-age under 5th percentile in children and adolescents. Rapid weight loss (e.g. more than 20% of total body weight within 6 months) may replace the low body weight guideline as long as other diagnostic requirements are met. Children and adolescents may exhibit failure to gain weight as expected based on the individual developmental trajectory rather than weight loss. Low body weight is accompanied by a persistent pattern of behaviours to prevent restoration of normal weight, which may include behaviours aimed at reducing energy intake (restricted eating), purging behaviours (e.g. self-induced vomiting, misuse of laxatives), and behaviours aimed at incr
Post a Comment
Read more

ICD-11 Criteria for Attention Deficit Hyperactivity Disorder (ADHD) 6A05

By
ICD-11 Criteria for Attention Deficit Hyperactivity Disorder (ADHD) 6A05 Attention deficit hyperactivity disorder is characterised by a persistent pattern (at least 6 months) of inattention and/or hyperactivity-impulsivity that has a direct negative impact on academic, occupational, or social functioning. There is evidence of significant inattention and/or hyperactivity-impulsivity symptoms prior to age 12, typically by early to mid-childhood, though some individuals may first come to clinical attention later. The degree of inattention and hyperactivity-impulsivity is outside the limits of normal variation expected for age and level of intellectual functioning. Inattention refers to significant difficulty in sustaining attention to tasks that do not provide a high level of stimulation or frequent rewards, distractibility and problems with organisation. Hyperactivity refers to excessive motor activity and difficulties with remaining still, most evident in structured situations that re
Post a Comment
Read more